![Alexion Pharmaceuticals / Eculizumab / Drug discovery / Paroxysmal nocturnal hemoglobinuria / Clinical trial / Glycogen storage disease type II / Health / Medicine / Rare diseases Alexion Pharmaceuticals / Eculizumab / Drug discovery / Paroxysmal nocturnal hemoglobinuria / Clinical trial / Glycogen storage disease type II / Health / Medicine / Rare diseases](https://www.pdfsearch.io/img/a57b62187398d430c2266b3ecdaa12da.jpg) Date: 2015-05-06 06:45:36Alexion Pharmaceuticals Eculizumab Drug discovery Paroxysmal nocturnal hemoglobinuria Clinical trial Glycogen storage disease type II Health Medicine Rare diseases | | Alexion to Acquire Synageva to Strengthen Global Leadership in Developing and Commercializing Transformative Therapies for Patients with Devastating and Rare Diseases -- Expands Alexion’s metabolic franchise wiAdd to Reading ListSource URL: www.alexion-synagevatransaction.comDownload Document from Source Website File Size: 444,87 KBShare Document on Facebook
|